6th Nov’20 – Sep’20 earnings update on Suven Pharma and Can Fin Homes
Dear Members, We have released 6th Nov’20 – Sep’20 earnings update on Suven Pharmaceuticals and Can Fin Homes. For other updates, please refer the following link – https://katalystwealth.com/category/latest-updates/ Date: 6th Nov’20 Suven Pharmaceuticals (NSE – SUVENPHAR) – May’17 Alpha stock CMP – 325.75 (BSE); 326.60 (NSE) Rating – Positive – 5% weightage; this is not an investment advice (refer rating interpretation) Source: bseindia.com Suven Pharmaceuticals got demerged from Suven Lifesciences with the entire revenue generating businesses consisting of CRAMS,…
21st Aug’20 – Jun’20 earnings update on Chaman Lal and Suven Pharma
Dear Members, We have released 21st Aug’20 – Jun’20 earnings update on Chaman Lal Setia and Suven Pharmaceuticals. The same has been produced below. For other updates, please refer the following link – https://katalystwealth.com/category/latest-updates/ Date: 21st Aug’20 Chaman Lal Setia (BSE – 530307) – Sep’19 Alpha stock CMP – 99.85 (BSE) Rating – Positive – 4% weightage; this is not an investment advice (refer rating interpretation) Source: bseindia.com Chaman Lal has reported good set of numbers for the quarter ending…
[Report]: Suven Pharma/Suven Life – Beaten down in 2017…now up 200% since then
Dear Sir, Hope you are doing well and enjoying the run up in the stocks. Well, considering the fall of Mar’20 and the gloom and doom all around, the run up has been truly exceptional with the portfolios moving up by 40% (since March lows) and some individual stocks up more than 50-100% and even more. Luckily for us as well, a lot of stocks have seen a great run up and helping us outperform benchmark indices by a wide…